Preclinical drug discovery research and training at Vanderbilt

ACS Chemical Biology

Volumn 2, Issue 1, 2007, Pages 17-20

  Lindsley, Craig W ^a,b   Weaver, David ^a   Jones, Carrie ^a   Marnett, Larry ^a   Conn, P Jeffrey ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; DRUG; G PROTEIN COUPLED RECEPTOR; ION CHANNEL;

ARTICLE; CELL DEATH; CONCENTRATION RESPONSE; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG HALF LIFE; DRUG RESEARCH; DRUG SCREENING; ENZYME INHIBITION; HIGH THROUGHPUT SCREENING; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PLASMA PROTEIN BINDING; POSTGRADUATE EDUCATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; STRUCTURE ACTIVITY RELATION; ACADEMIC ACHIEVEMENT; DRUG DESIGN; METHODOLOGY; PHARMACEUTICS; UNITED STATES; UNIVERSITY; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; EDUCATION, GRADUATE; HUMANS; TECHNOLOGY, PHARMACEUTICAL; TENNESSEE; UNIVERSITIES;

EID: 33947534321     PISSN: 15548929     EISSN: None     Source Type: Journal    
DOI: 10.1021/cb6004867     Document Type: Article

References (1)

1. Sulikowski, M. M., and Bachmann, B. O. (2006) Designing a curriculum that goes beyond a list of topics, ACS Chem. Biol. 1, 489-491.